Aspectos evolutivos dos fenômenos imunopatológicos com ênfase na COVID-19
Evolutionary aspects of immunopathological phenomena with emphasis on COVID-19
Selma Giorgio; Pedro Henrique Gallo-Francisco
Resumo
A seleção natural é o principal mecanismo da evolução das espécies, e favorece fenótipos com defesas imunes efetivas contra patógenos. Entretanto, há uma grande variação das respostas imunes entre os indivíduos da espécie humana e a ocorrência de fenômenos imunopatológicos. A infecção com o vírus da família Coronaviridae, SARS-CoV-2, responsável pela doença conhecida como COVID-19, induz a respostas imunes inflamatórias exacerbadas e à tempestade de citocinas, nos casos graves. Nesta revisão discutiremos, à luz da Evolução, esse aparente paradoxo entre as respostas imunes, e os três principais fatores que contribuem para a manutenção dos fenótipos hiperativos: o custo-benefício das respostas imunes, a coevolução e a história de vida da espécie.
Palavras-chave
Abstract
Natural selection is the main mechanism by which species evolve, and it favors phenotypes associated with an effective immune defense against pathogens. However, human immune responses and the occurrence of immunopathological phenomena vary considerably from individual to individual. Infection with SARSCoV-2, a virus of the Coronaviridae family causing the disease known as COVID-19, induces exacerbated inflammatory immune responses and cytokine storm in severe cases. In this review, we discuss, in the light of Evolution, this apparent paradox between the immune responses and the 3 main factors contributing to the maintenance of hyperactive phenotypes: the cost-effectiveness of immune responses, coevolution, and the life history of the species.
Keywords
References
1. Miescher PA, Muller-Eberhard HJ. Preface. Springer Seminars Immunopatol. 1978;1:1-2.
2. Sell S. Immunopathology Teaching Monography. Am J Pathology. 1978;90(1):211-79.
3. Germain RN. Maintaining system homeostasis: the third law of Newtonian immunology. Nature Immunol. 2012; 13(10):902-6. doi: 10.1038/ni.2404.
4. Barnaba V, Paroli M, Piconese S. The ambiguity in immunology. Front Immunol. 2012. doi: 10.3389/fimmu.2012.00018.
5. Graham AL, Allen JE, Read AF. Evolutionary causes and consequences of immunopathology. Annu Rev Evol Syst. 2005;56:373-97. doi: 10.1146/annurev.ecolsys.36.102003.152622.
6. Aarestrup FM. Imunopatologia da COVID-19 e suas implicações clínicas. Arq Asma Alerg Imunol. 2020;4(2):172-80. doi: 10.5935/2526-5393.20200024.
7. Giavina-Bianchi P. Surfando a terceira onda. Arq Asma Alerg Imunol. 2022;6(1):1-3. doi: 10.5935/2526-5393.20220001.
8. Fara A, Mitrev Z, Rosalia RA, Assas BM. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol. 2020;10:200160. doi: 10.1098/rsob.200160.
9. Wong L-YR, Perlman S. Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronavirus-are we own worst enemy? Nat Rev Immunol. 2022; 22(1):47-56. doi: 10.1038/s41577-021-00656-2.
10. Finlay BB, Amato KR, Azad M, Blaser MJ, Bosch TCG, Chu H, et al. The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome. PNAS. 2021; 118(6): e2010217118. doi: 10.1073/pnas.2010217118.
11. Sorci G, Cornet S, Faivre B. Immune evasion, immnopathology and the regulation of the immune system. Pathogens. 2013:2:71-91. doi: 10.3390/pathogens2010071.
12. Brinkworth JF, Barreiro LB. The contribution of natural selection to present-day susceptibility to chronic inflammatory and autoimmune disease. Curr Opin Immunol. 2014;31:76-78. doi: 10.1016/j.coi.2014.09.008.
13. Iwasaki A, Medzhitov R. A new shield for a cytokine storm. Cell. 2011;146(6):861-2. doi: 10.1016/j.cell.2011.08.027.
14. Waizbort RF, Luz MRMP. Medicina Evolutiva: Incorporando a Teoria da Evolução na Formação de Profissionais de Saúde Brasileiros. Rev bras educ med. 2017;41(4). doi: 10.1590/1981-52712015v41n4RB20160074.
15. Lazzaro BP, Tate AT. Balancing sensitivity, risk, and immunopathology in immune regulation. Curr Opinion Insect Sci. 2022;50:100874. doi: 10.1016/j.cois.2022.100874.
16. Okin D, Medzhitov R. Evolution of inflammatory diseases. Curr Biol. 2012:22(17)R733-49. doi: 10.1016/j.cub.2012.07.029.
17. Graham Al. Optimal immunity meets natural variation: the evolutionary biology of host defence. Parasite Immunol. 2013;35:315-7. doi:10.1111/ pim.12073 9.
18. Metcalf CJE, Tate AT, Graham AL. Demographically framing tradeoffs between sensitivity and specificity illuminates selection on immunity. Nature Ecol Evol.2017; 1:1766-72. doi:10.1038/s41559- 017-0315-3.
19. Aldakak L, Ruhli F, Galipaud M, Bender N. The evolution of immune sensitity under immunopathological and autoimmune costs, BioRxiv. 2020. doi: 10.1101/2020.10.12.335620.
20. Chen X, Liu S, Goraya MU, Maarouf M, Huang S, Chen J-L. Host immune response to Influenza A virus infection. Front Immunol. 2018;9:320. doi: 10.3389/fimmu.2018.00320.
21. Taubenberger JK, Morens DM. The pathology of Influenza virus infections. Ann Rev Pathol. 2008;3:499-522. doi: 10.1146/annurev.pathmechdis.3.121806.154316.
22. Betts A, Rafaluk C, King KC. Host and parasite evolution in a tangled bank. Trends Parasitol. 2016;32(11): 863-73. doi: 10.1016/j. pt.2016.08.003.
23. Paludan SR, Pradeu T, Masters SL, Mogensen TH. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat Rev Immunol. 2021;21(3):137-50. doi: 10.1038/s41577-020-0391-5.
24. Sorci G, Lippens C, Léchenault C, Faivre B. Benefits of immune protection versus immunopathology costs: A synthesis from cytokine KO models. Infect Genet Evol. 2017;54:491-95. doi: 10.1016/j.meegid.2017.08.014.
25. Dienz O, Rud LG, Eaton SM, Lanthier PA, Burg E, Drew A et al. Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung. Mucosal Immunol. 2012;5(3):258-66. doi: 10.1038/mi.2012.2.
26. Tang-Feldman YJ, Lochlead GR, Lochlead SR, Yu C, Pomeroy C. Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice. Inflamm Res. 2011;60(3):233-43. doi: 10.1007/s00011-010-0259-4 5.
27. Rook GA. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis. Clin Exp Immunol 2010;160(1):70-9. doi: 10.1111/j.1365-2249.2010.04133.x.
28. Rook GA, Lowry CA, Raison CL. Microbial 'Old Friends', immunoregulation and stress resilience. Evol Med Public Health. 2013; 1:46-64. doi: 10.1093/emph/eot004.
29. Maizels RM, McSorley HJ. Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol 2016: 138(3):666-75. doi: 10.1016/j.jaci.2016.07.007.
30. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, et al. The aryl hydrocarbon receptor links TH17-cellmediated autoimmunity to environmental toxins. Nature. 2008 May 1;453(7191):106-9. doi: 10.1038/nature06881.
31. Ahlstrom T. Life-history theory, past human populations and climatic perturbations. Int J Ostearchaeol. 2011; 21(40):407-19. doi: 10.1002/oa.1147.
32. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11:398-411.
33. Aoshiba K, Tsuji T, Itoh M, Yamagushi K, Nakamura H. An evolutionary medicine approach to understanding factors that contribute to chronic obstructive pulmonary disease. Respiration. 2015; 89:243‑52. doi:10.1159/000369861.
Submitted date:
03/23/2022
Accepted date:
07/15/2022
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email